Thursday, April 01, 2021 9:41:28 AM
Verdemed supplies cannabis products in Brazil under the compassionate use model and has submitted applications to register finished products in Brazil and Peru. The products manufactured under this partnership will be registered as pharmaceutical products and sold into distribution channels such as pharmacies and drugstores.
“Verdemed is an important player in the Brazilian market with existing access to patients and is well-positioned to tackle the high regulatory hurdles in Brazil and Peru. This partnership expands Clever Leaves’ presence in one of the largest markets in South America,” said Kyle Detwiler, CEO of Clever Leaves. “We are committed to increasing access for the millions of patients within the growing Brazilian and Peruvian markets, and they will soon have access to the high-quality products we produce thanks to Verdemed’s network.”
“Partnering with Clever Leaves aligns with Verdemed’s mission to offer the best cannabinoid products to all Latin Americans,” said José Bacellar, CEO of Verdemed. “Clever Leaves’ products meet all of the regulatory and product quality standards in each of our key markets, and their EU GMP and INVIMA GMP certifications distinguish their products and bring higher value to patients.”
The Brazilian and Peruvian markets are expanding, and it is estimated that the Brazilian medical cannabis user base could reach close to 3 million people in the next few years. According to Prohibition Partners, with a population of 32 million, Peru’s medical cannabis market is estimated to be worth approximately $100 million. As of September 2020, almost 8,000 patients were registered in the DIGEMID, Peru’s drug regulatory authority database.
About Verdemed Holdings Inc.
Verdemed brings affordable cannabinoid-based pharmaceuticals to doctors and patients in Latin America, in all countries, in all jurisdictions legally authorized to sell medical cannabis. The company’s initial focus is on product formulations of cannabinoid pharmaceuticals currently available in Canada, Europe, and the USA.
Verdemed established a wholly-owned, active-controlled substances pharmaceutical import laboratories in Brazil and Peru, which are registered in compliance with Anvisa and DIGEMID for cannabis-derived products. Its goal is to scale-up exclusive strategic supply chain partnerships with GMP-certified API providers for the industrial production of pharmaceutical grade CBD oil formulations.
About Clever Leaves Holdings Inc.
Clever Leaves is a multi-national cannabis company with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community. Clever Leaves has received multiple international certifications that have enabled it to increase its export and sales capacity from its Colombian operations, including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute - INVIMA, and Good Agricultural and Collecting Practices (GACP) Certification. Clever Leaves was granted a license in Portugal from Infarmed – the Portuguese health authority – which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes. In addition, the Portuguese operation was granted certification of compliance with GACP and IMC-GAP.
My posts may consist of facts, speculative insights, be opinion based, and should not be considered as investment or trading advice. GLTA and happy trading!
Recent CLVR News
- Clever Leaves Announces Voluntary Delisting and SEC Deregistration • GlobeNewswire Inc. • 04/26/2024 08:10:00 PM
- Clever Leaves Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 04/01/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:01:46 PM
- Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia • GlobeNewswire Inc. • 02/13/2024 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/01/2024 10:13:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:11:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:04:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:03:21 PM
- Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:19:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:13:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:11:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 10:00:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/09/2023 09:09:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:04:18 PM
- Clever Leaves Reports Third Quarter 2023 Results • GlobeNewswire Inc. • 11/09/2023 09:01:00 PM
- Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET • GlobeNewswire Inc. • 11/02/2023 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/23/2023 08:52:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:15:43 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM